Lung cancer drug response tied to tumor type: study
Testing lung cancer patients for tumor markers would enable doctors to choose which drug the patient is most likely to respond to, improving the chances for successful treatment, according to results from a recent trial.
Read more on Reuters via Yahoo! News
Product Description
An updated and expanded edition of a highly lauded plan for preventing and fighting cancer through a macrobiotic natural-foods diet offers new cases, updates on the disease, inspirational advice, and delicious new recipes…. More >>
Ze-Guang Han and colleagues, at the Chinese National Human Genome Center at Shanghai, People’s Republic of China, have now identified SCARA5 as a candidate tumor suppressor gene in human hepatocellular carcinoma (HCC), a form of liver cancer that is the fifth most common cancer worldwide.
The research is reported in the Journal of Clinical Investigation.
» Read more: New Suppressor of Common Liver Cancer